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748Objective: Minimally invasive approaches to mitral valve surgery are increasingly used, but the surgical ap-
proach must not compromise the clinical outcome for improved cosmesis. We examined the outcomes of mitral
repair performed through right minithoracotomy or median sternotomy.
Methods: Between January 2002 and October 2011, 1011 isolated mitral valve repairs were performed in the
University of Pennsylvania health system (455 sternotomies, 556 right minithoracotomies). To account for key
differences in preoperative risk profiles, propensity scores identified 201 well-matched patient pairs with mitral
regurgitation of any cause and 153 pairs with myxomatous disease.
Results: In-hospital mortality was similar between propensity-matched groups (0% vs 0% for the degenerative
cohort; 0% vs 0.5%, P ¼ .5 for the overall cohort; in minimally invasive and sternotomy groups, respectively).
Incidence of stroke, infection, myocardial infarction, exploration for postoperative hemorrhage, renal failure,
and atrial fibrillation also were comparable. Transfusion was less frequent in the minimally invasive groups
(11.8% vs 20.3%, P ¼ .04 for the degenerative cohort; 14.0% vs 22.9%, P ¼ .03 for the overall cohort),
but time to extubation and discharge was similar. A 99% repair rate was achieved in patients with myxomatous
disease, and a minimally invasive approach did not significantly increase the likelihood of a failed repair result-
ing in mitral valve replacement. Patients undergoing minimally invasive mitral repair were more likely to have
no residual post-repair mitral regurgitation (97.4% vs 92.1%, P ¼ .04 for the degenerative cohort; 95.5% vs
89.6%, P ¼ .02 for the overall cohort). In the overall matched cohort, early readmission rates were higher in
patients undergoing sternotomies (12.6% vs 4.4%, P¼ .01). Over 9 years of follow-up, there was no significant
difference in long-term survival between groups (P ¼ .8).
Conclusions: In appropriate patients with isolated mitral valve disease of any cause, a right minithoracotomy
approach may be used without compromising clinical outcome. (J Thorac Cardiovasc Surg 2013;145:748-56)During the past 20 years, the increasing popularity of less-
invasive procedures has affected nearly every surgical spe-
cialty, including cardiac surgery. Advancements in imaging,
surgical instrumentation, and robotic technology have en-
abled surgeons to perform complex cardiac surgical proce-
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The Journal of Thoracic and Cardiovascular Surgsternotomy or cardiopulmonary bypass.1-4 In addition to
benefits of improved cosmesis, minimally invasive mitral
valve surgery was pioneered with the intent of reducing
morbidity, postoperative pain, blood loss, hospital length
of stay, and time to return to normal activity.5,6 Although
clinical studies support many of the theoretical advantages
of less-invasive approaches tomitral valve surgery, no defin-
itive randomized trial has been conducted to date.6-12
Treatment allocation bias inherent in retrospective studies
begets significant differences in baseline risk profiles of
minimally invasive and sternotomy groups, often with the
higher-risk patients in the sternotomy cohort. Propensity
score analysis helps to control for such bias, but requires
a large study population, and only a handful of such studies
have been published thus far.13-17
Just as novel operative techniques have developed, the
management of mitral regurgitation (MR) continues to
change as our knowledge of the disease pathophysiology
evolves. Treatment paradigms have shifted to identifyery c March 2013
Abbreviation and Acronym
MR ¼ mitral regurgitation
Goldstone et al Acquired Cardiovascular Diseasepatients earlier in the disease course, before the develop-
ment of adverse sequelae of long-standing MR on left ven-
tricular function and geometry.18 In the setting of
degenerative mitral valve disease, there exists a growing ad-
vocacy for referral of asymptomatic patients for surgery.18,19
As minimally invasive approaches to mitral valve surgery
are increasingly used, and mitral valve repair has now
extended to the asymptomatic population, it is essential
that the surgical approach not compromise the clinical
outcome for improved cosmesis. We sought to compare
the early and late outcomes of isolated mitral valve repair
performed through right minithoracotomy and median
sternotomy at a high-volume academic health system.A
C
DMATERIALS AND METHODS
Study Population
Between January 2002 and October 2011, 4241 mitral valve operations
were performed within the University of Pennsylvania Health system. The
study population was limited to adult patients who underwent isolated mi-
tral valve repair (n ¼ 1011), defined as any mitral valve repair procedure
performed in the absence of a major concomitant procedure (eg, coronary
bypass, other valve surgery, or aortic surgery). To avoid intention-to-treat
selection bias, a subgroup analysis of patients who underwent isolated mi-
tral valve replacement (n¼ 272) during the same study period also was an-
alyzed. Data were in part retrieved from the University of Pennsylvania’s
prospective Society of Thoracic Surgeon’s registry and partially obtained
from each patient’s medical record. These data were approved for use in
research by the University of Pennsylvania Institutional Review Board
with a waiver of patient consent.
Operative Technique
The definition of minimally invasive mitral valve surgery is broad and
generally inclusive of any operation performed through less than a conven-
tional median sternotomy. For the purpose of the present study, this defini-
tion was narrowed to include only isolated mitral valve repairs performed
through a right minithoracotomy. A conventional median sternotomy ap-
proach was used in 455 patients (44%), and a minimally invasive approach
was used in 556 patients (66%). The main determinant of the surgical ap-
proach used was the preference of the patient or referring cardiologist, with
absolute contraindications including only severe peripheral arterial disease
and high-grade atheroma of the descending aorta.
Minimally invasive mitral valve repair was performed using stand-
ardized methods similar to those previously described.1,3,10,13,20 Briefly,
standard monitoring lines are placed and the patient is intubated with
a double-lumen endotracheal tube. Before draping, the right internal jugu-
lar vein is cannulated with a 16F femoral cannula. Access to the thoracic
cavity is achieved via a 4-cm incision in the inframammary groove that
is carried through the third or fourth intercostal space. A soft tissue retrac-
tor is used to limit rib spreading. Femoral venous cannulation is performed
with a 22F or 25F cannula, and femoral arterial cannulation is performed
with a 14F, 16F, or 18F cannula depending on body size, or a 21F cannula
with a side port if using endoaortic occlusion. The opened pericardium is
retracted toward the right. Before cannulation, a complete echocardio-
graphic assessment of the ascending aorta is performed. Cardiopulmonary
bypass is initiated, and the heart is arrested with antegrade cold bloodThe Journal of Thoracic and Cacardioplegia. When the heart is accessed throughmedian sternotomy, myo-
cardial protection is achieved with antegrade and retrograde cold blood car-
dioplegia. Use of retrograde cardioplegia during minimally invasive mitral
repair depends on surgeon preference. In approximately 30% of cases, an
endoaortic balloon (Edwards Lifesciences, LLC, Irvine, Calif) was used for
proximal aortic occlusion. The balloon is positioned under transesophageal
echocardiographic guidance just above the sinotubular junction with care-
ful attention paid to bilateral radial artery pressures. Otherwise, central aor-
tic cannulation was performed via the initial thoracotomy incision, and
aortic occlusion was accomplished with transthoracic clamping (Chitwood
clamp; Scanlan International Inc, Minneapolis, Minn). After cardiac arrest,
the left atrium is entered along the interatrial groove. Mitral valve repair is
performed using standardized techniques. Carbon dioxide field insufflation
and standardized transesophageal echocardiography–guided de-airing
techniques are routinely used to help minimize risk of air embolus. After
atrial closure and separation from cardiopulmonary bypass, a complete
postoperative transesophageal echocardiographic study is recorded. Post-
repair echocardiographic data were obtained after incision closure.
Statistical Analysis
Continuous variables are expressed as the mean  standard deviation,
and categorical variables are presented as proportions. Comorbid diagnoses
and perioperative outcome variables adhere to the definitions of the Society
of Thoracic Surgeons National Database. Differences between groups were
assessed using the Fisher exact test for categorical variables, the indepen-
dent Student t test for normally distributed continuous variables, and the
Mann–Whitney U test for non-normally distributed continuous variables.
Survival analyses were performed using Kaplan–Meier survival analysis
with log-rank tests. All tests were 2-tailed.
The propensity to undergo minimally invasive mitral valve repair was
calculated using multivariable logistic regression to model a dichotomous
outcome of minimally invasive or open repair for all patients in the sample,
as well as for only patients with degenerative mitral valve disease. Eleven
fixed-effect variableswere included in the finalmodel (Appendices 1 and 2).
Patients with similar propensity scores were matched in a 1:1 nearest
neighbor fashion across the total distribution of propensity scores.Although
a difference in propensity score less than 0.1 was required for a match, the
majority of matches did not approach this limit (median difference, 0.0015;
interquartile range, 0.0005-0.008). Matched pairs were identified across
a wide range of propensity scores (Figure 1). The statistical analysis was
performed using SAS for Windows (SAS Institute, Inc, Cary, NC) and
IBMSPSS Statistics forMacintosh, version 19.0 (SPSS, Inc, Armonk, NY).RESULTS
Baseline demographics and comorbidity profiles are
summarized in Table 1. Patients undergoing the minimally
invasive procedure were more likely to have less symptom-
atic MR due to degenerative mitral valve disease, as well as
higher ejection fractions and less concomitant tricuspid re-
gurgitation. Fewer patients in the minimally invasive cohort
had hypertension, chronic lung disease, or endocarditis.
Two separate propensity score analyses were conducted to
account for differences in baseline characteristics in the
study population: (1) a matched comparison of patients
with mitral valve disease of any cause (n ¼ 402) or (2)
a matched comparison limited to only patients with degen-
erative mitral valve disease (n ¼ 306) (Table 2). In both
comparisons, matched groups were similar with regard to
all preoperative comorbidity, hemodynamic, and demo-
graphic categories.rdiovascular Surgery c Volume 145, Number 3 749
FIGURE 1. Mirrored histogram of distribution of propensity scores for sternotomy (bars above zero line) and minimally invasive (bars below zero line)
approaches for overall matched cohort (A) and degenerative matched cohort (B). Green areas represent matched patient pairs and demonstrate that the
sample consisted of nearly the complete spectrum of cases.
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subgroup comparisons, ischemic and cardiopulmonary by-
pass times were significantly longer in those undergoing theTABLE 1. Demographics and clinical characteristics of patients
undergoing mitral valve repair: Entire study population
Variable
Median
sternotomy
(n ¼ 455)
Minimally
invasive
(n ¼ 556)
P
value
Demographics
Age (y) 57.7  13.6 57.6  12.7 1.0
Gender (% female) 174 (38.2%) 211 (37.9%) .9
BMI (kg/m2) 26.6  5.4 26.7  7.6 .8
Comorbidities
Chronic kidney disease 27 (5.9%) 20 (3.6%) .1
Hypertension 233 (51.3%) 237 (42.7%) .006
Infective endocarditis 42 (9.3%) 27 (4.9%) .008
Chronic lung disease 58 (12.8%) 43 (7.7%) .008
Peripheral arterial disease 14 (3.1%) 11 (2.0%) .3
Cerebrovascular disease 37 (8.2%) 37 (6.7%) .4
Previous cardiac surgery 57 (12.6%) 64 (11.5%) .6
NYHA functional class <.001
I 111 (25.1%) 139 (25.1%)
II 186 (42.0%) 304 (55.0%)
III 132 (29.8%) 86 (15.6%)
IV 14 (3.2%) 24 (4.3%)
Cause .003
Degenerative 280/401 (61.5%) 242/298 (81.2%)
Functional 65/401 (16.2%) 30/298 (10.1%)
Rheumatic 4/401 (1.0%) 5/298 (1.7%)
Other 52/401 (13.0%) 21/298 (7.0%)
Echocardiography
Ejection fraction (%) 54.2  14.5 56.0  11.5 .04
Severe MR 442 (97.4%) 547 (98.4%) .3
Mild or greater TR 252 (55.9%) 127 (23.8%) <.001
Continuous variables are expressed as means  standard deviation. BMI, Body mass
index; NYHA, New York Heart Association; MR, mitral regurgitation; TR, tricuspid
regurgitation.
750 The Journal of Thoracic and Cardiovascular Surgminimally invasive procedure (104  32 minutes vs
82  31 minutes [P< .001] and 138  41 minutes vs
107  37 minutes [P<.001], respectively, for the degenera-
tive matched cohort; 101  32 minutes vs 82  39 minutes
[P< .001] and 137  42 minutes vs 108  48 minutes
[P<.001], respectively, for the overall matched cohort). Sig-
nificant systolic anterior motion of themitral valvewas noted
in 2 patients with mitral valve prolapse, both within the ster-
notomygroup, and post-repair ejection fractionwas compara-
ble between groups.Within eachmatched subgroup analysis,
patients undergoing minimally invasive mitral valve repair
were more likely to have no residual post-repair MR
(97.4% vs 92.1%, P¼ .04 for degenerative matched cohort;
95.5% vs 89.6%, P ¼ .02 for overall matched cohort), with
the remainder exhibiting trace or mild post-repair MR. Of
note, nonresectional leaflet remodeling and neochordae tech-
niqueswereusedmore frequently in patients undergoingmin-
imally invasive mitral valve repair. There was a higher
incidence of bileaflet prolapse within the sternotomy group
compared with the minimally invasive group in the overall
matched analysis (20.9% vs 11.4%, P¼ .03). Complete an-
nuloplasty ringswere used in nearly every patient, but flexible
ringswere implantedmore often than semirigid rings formin-
imally invasive mitral valve repairs.
During the study interval, 272 patients underwent mitral
valve replacement. Overall, 193 mitral replacements were
performed via median sternotomy and 79 were performed
via right minithoracotomy. Seventy-nine patients received
a mitral valve prosthesis for mitral stenosis. The majority
of the remaining patients underwent mitral valve replace-
ment for endocarditis (29.9%), rheumatic MR (14.6%), se-
vere mitral annular calcification (13.1%), prosthetic failure
(10.9%), or ischemic cardiomyopathy (4.0%), and were
randomized to the mitral valve replacement cohort within
the NHLBI Cardiothoracic Surgery Trials Network trial,ery c March 2013
TABLE 2. Demographics and clinical characteristics of patients undergoing mitral valve repair: Propensity-matched cohorts
Variable
Any cause Degenerative only
Median sternotomy
(n ¼ 201)
Minimally invasive
(n ¼ 201) P value
Median sternotomy
(n ¼ 153)
Minimally invasive
(n ¼ 153) P value
Demographics
Age (y) 57.0  12.8 57.1  12.4 .9 57.1  12.8 56.6  12.1 .7
Gender (% female) 71 (35.5%) 68 (33.7%) .8 57 (37.3%) 51 (33.3%) .6
BMI (kg/m2) 26.2  4.4 26.2  4.3 1.0 25.8  4.2 25.8  4.2 .9
Comorbidities
Chronic kidney disease 6 (3.0%) 6 (3.0%) 1.0 2 (1.3%) 2 (1.3%) 1.0
Hypertension 95 (47.5%) 84 (41.6%) .3 61 (39.9%) 63 (41.2%) .9
Infective endocarditis 18 (9.0%) 9 (4.5%) .08 7 (4.6%) 5 (3.3%) .8
Chronic lung disease 20 (10.0%) 18 (9.0%) .7 12 (7.8%) 13 (8.5%) 1.0
Peripheral arterial disease 2 (1.0%) 5 (2.5%) .5 0 (0%) 2 (1.3%) .5
Cerebrovascular disease 14 (7.0%) 14 (7.0%) 1.0 8 (5.3%) 6 (3.9%) .6
Previous cardiac surgery 16 (8.0%) 14 (7.0%) .7 8 (5.3%) 6 (3.9%) .6
NYHA functional class .3 .5
I 58 (28.9%) 67 (33.3%) 47 (30.7%) 53 (34.6%)
II-IV 143 (71.1%) 134 (66.7%) 106 (69.3%) 100 (65.4%)
Cause .9 1.0
Degenerative 156 (77.6%) 158 (78.6%) 153 (100.0%) 153 (100.0%)
Functional 21 (10.4%) 21 (10.4%) — —
Other 24 (12.0%) 22 (8.5%) — —
Echocardiography
Ejection fraction (%) 56.7  11.9 57.0  9.5 .8 58.1  9.3 58.3  7.7 .8
Severe MR 201 (100.0%) 201 (100.0%) .3 153 (100.0%) 153 (100.0%) 1.0
Moderate or greater TR 39 (19.4%) 39 (19.4%) 1.0 31 (20.3%) 30 (19.6%) 1.0
Leaflet prolapse .03 .14
Anterior 14 (7.0%) 14 (7.0%) 10 (6.5%) 10 (6.5%)
Posterior 126 (62.7%) 144 (71.6%) 104 (68.0%) 118 (77.1%)
Bileaflet 42 (20.9%) 23 (11.4%) 39 (25.5%) 25 (16.3%)
Continuous variables are expressed as means  standard deviation. BMI, Body mass index; NYHA, New York Heart Association; MR, mitral regurgitation; TR, tricuspid
regurgitation.
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Sixteen patients with degenerative MR received a mitral
valve prosthesis; 25% were emergency procedures, and
50% of patients were more than 70 years of age. Seven pa-
tients underwent unsuccessful attemptedmitral repair (99%
repair rate for degenerative MR), and a minimally invasive
approach did not significantly increase the likelihood of
a failed repair resulting in mitral valve replacement (0.2%
vs 1.0%, P ¼ .1, in the sternotomy and minimally invasive
groups, respectively).
In-hospital outcomes are summarized in Table 4. The in-
cidence of postoperative hemorrhage requiring exploration
did not differ between matched groups, yet transfusion was
less frequent in patients who underwent minimally invasive
surgery (11.8% vs 20.3%, P ¼ .04 for the degenerative
matched cohort; 14.0% vs 22.9%, P ¼ .03 for the overall
matched cohort). Duration of postoperative ventilatory
support and incidence of stroke, renal failure, sepsis, atrial
fibrillation, and deep wound infection were similar between
both matched groups. Length of intensive care unit stay,
total hospital length of stay, and likelihood of discharge
home were comparable between groups. However, in theThe Journal of Thoracic and Caoverall matched cohort, patients undergoing the minimally
invasive procedure were less likely to be readmitted within
30 days after discharge compared with patients undergoing
conventional sternotomy (4.4% vs 12.6%, P¼ .01). Hospi-
tal mortality rates did not significantly differ between the
minimally invasive and sternotomy groups (0% vs 0%
for the degenerative matched cohort; 0% vs 0.5%
[n ¼ 1], P ¼ .5 for the overall matched cohort).
Survival data are illustrated in Figures 2 and 3. Median
follow-up was 4.2 years (interquartile range, 1.9-6.8). For
matched patients with degenerative mitral valve disease, sur-
vival at 1, 5, and 9 years was 99%, 99%, and 99%, respec-
tively, after minimally invasive surgery, and 99%, 97%,
and 95%, respectively, after conventional sternotomy
(P ¼ .8). In the overall matched population, 1-, 5-, and 9-year
survival was 96%, 96%, and 96%, respectively, after mini-
mally invasive mitral valve repair, and 97%, 92%, and 89%,
respectively, after the conventional approach (P¼ .8).
DISCUSSION
There is an increasing demand from patients and refer-
ring physicians for less-invasive mitral valve surgery.rdiovascular Surgery c Volume 145, Number 3 751
TABLE 3. Operative and echocardiographic data stratified by operative approach: Propensity-matched cohorts
Variable
Any cause Degenerative only
Median sternotomy
(n ¼ 201)
Minimally invasive
(n ¼ 201) P value
Median sternotomy
(n ¼ 153)
Minimally invasive
(n ¼ 153) P value
Crossclamp time (min) 82.3  38.5 101.3  32.4 <.001 81.9  30.7 103.7  31.6 <.001
Bypass time (min) 108.1  48.3 136.8  42.0 <.001 106.8  36.8 138.1  41.2 <.001
Repeat bypass run 9 (4.5%) 6 (3.0%) .4 6 (3.9%) 5 (3.3%) .8
Significant SAM 2 (1.0%) 0 (0%) .3 2 (1.3%) 0 (0%) .5
Ring type
Flexible 14 (7.0%) 105 (52.2%) <.001 9 (5.9%) 90 (58.8%) <.001
Semirigid/rigid 187 (93.0%) 96 (47.8%) 144 (94.1%) 63 (41.2%)
Incomplete 5 (2.5%) 1 (0.5%) .1 0 (0%) 1 (0.7%) 1.0
Complete 196 (97.5%) 200 (99.5%) 153 (100%) 152 (99.3%)
Repair strategy <.001 <.001
Leaflet resection 136 (67.7%) 105 (52.2%) 121 (79.1%) 98 (64.1%)
Neochordae 16 (8.0%) 37 (18.4%) 15 (9.8%) 29 (19.0%)
Leaflet remodeling 15 (7.5%) 32 (15.9%) 4 (2.6%) 19 (12.4%)
Annuloplasty alone 29 (14.4%) 19 (9.5%) 10 (6.5%) 5 (3.3%)
Post-repair MR .04 .04
None 181 (90.0%) 192 (95.5%) 140 (92.1%) 148 (97.4%)
Trace/mild 20 (10.0%) 9 (4.5%) 12 (7.9%) 4 (2.6%)
Moderate 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Post-repair EF (%) 57.8  14.2 56.6  10.7 .3 58.4  12.0 57.5  9.5 .5
Continuous variables are expressed as means  standard deviation. SAM, Systolic anterior motion; MR, mitral regurgitation; EF, ejection fraction.
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DMinimally invasive approaches to the mitral valve are well
described, with most surgeons using a lower hemisternot-
omy or right minithoracotomy to access the heart. Initial
concerns focused on the greater risk of longer operations
and peripheral cannulation at the expense of improved
cosmesis. Yet, despite a paucity of objective evidence to
assuage these concerns and demonstrate therapeutic equiv-
alence, minimally invasive platforms for mitral valve
surgery have been increasingly adopted. The recent consen-
sus statement from the International Society of MinimallyTABLE 4. In-hospital outcomes stratified by operative approach: Propens
Outcome
Any cause
Median sternotomy
(n ¼ 201)
Minimally invasive
(n ¼ 201)
Death 1 (0.5%) 0 (0%)
MI 0 (0%) 1 (0.5%)
Deep infection 0 (0%) 0 (0%)
Sepsis 2 (1.0%) 0 (0%)
Stroke 1 (0.5%) 0 (0%)
Renal failure 3 (1.5%) 2 (1.0%)
Gastrointestinal event 3 (1.5%) 0 (0%)
Exploration for hemorrhage 1 (0.5%) 5 (2.5%)
Transfusion 44 (22.9%) 28 (14.0%)
Atrial fibrillation 50 (25.0%) 42 (20.8%)
Time to extubation (h) 8.0 (6.0-13.0) 8.0 (6.0-12.0)
Time to discharge (d) 6.0 (5.0-8.0) 6.0 (5.0-7.0)
Discharge home 187 (93.5%) 193 (95.5%)
Readmission within 30 d 15 (12.6%) 7 (4.4%)
Continuous variables are expressed as medians with interquartile range. MI, Myocardial i
752 The Journal of Thoracic and Cardiovascular SurgInvasive Coronary Surgery assigned a class IIb recommen-
dation for minimally invasive surgery for mitral valve
disease.21 The present study affirms the noninferiority of
minimally invasive mitral valve surgery via right minithor-
acotomy. Although procedure time is lengthened, risks are
comparable or less, transfusions are less frequent, duration
of ventilatory support is similar, hospital length of stay is
equivalent, and long-term survival is similarly excellent.
Several reports have examined key outcomes after mini-
mally invasivemitral valve surgery.22-24 As in the Society ofity-matched cohorts
Degenerative only
P value
Median sternotomy
(n ¼ 153)
Minimally invasive
(n ¼ 153) P value
.5 0 (0%) 0 (0%) —
.5 0 (0%) 1 (0.7%) 1.0
— 0 (0%) 0 (0%) —
.2 0 (0%) 0 (0%) —
.5 1 (0.7%) 0 (0%) 1.0
.7 1 (0.7%) 0 (0%) 1.0
.1 1 (0.7%) 0 (0%) 1.0
.2 1 (0.7%) 3 (2.0%) .4
.03 31 (20.3%) 18 (11.8%) .04
.3 34 (22.2%) 29 (19.0%) .6
.3 8.0 (5.0-13.0) 7.8 (5.8-12.0) .8
.4 6.0 (5.0-7.0) 6.0 (5.0-7.0) .9
.4 144 (94.1%) 149 (97.4%) .3
.01 8 (5.2%) 7 (4.6%) 1.0
nfarction.
ery c March 2013
FIGURE 2. Survival after mitral valve repair stratified by operative ap-
proach: overall matched cohort. Numbers of patients at risk are included
in the corresponding table. MICS, Minithoracotomy.
FIGURE 3. Survival after mitral valve repair stratified by operative
approach: degenerative matched cohort. Numbers of patients at risk are
included in the corresponding table. MICS, Minithoracotomy.
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investigators broadly define minimally invasive surgery as
any procedure performed through less than a conventional
median sternotomy. Nonetheless, the results of the meta-
analyses to date are generally in accord. A meta-analysis
by Modi and colleagues22 included 2827 patients and re-
vealed lower rates of reoperation for postoperative hemor-
rhage, as well as a trend toward decreased hospital length
of stay. Richardson and colleagues23 included 13 studies
in their analysis and found that despite longer procedure
times, minimally invasive mitral surgery was associated
with reduced postoperative bleeding, faster times to extuba-
tion, less pain, and a more swift return to regular activity.
Most recently, Cheng and colleagues24 examined the results
of 35 studies (2 randomized, 33 nonrandomized) that ex-
cluded patients undergoing lower hemisternotomies from
the minimally invasive group, but did include mitral valve
replacements. A number of key outcomes were significantly
improved with minimally invasive mitral valve surgery, in-
cluding incidence of postoperative atrial fibrillation, post-
operative bleeding and transfusion requirement, time to
return to normal activity, and cosmetic indices of scar satis-
faction. Despite longer procedure times, hospital length of
stay and time to extubation were reduced. However, mini-
mally invasive mitral valve surgery was not without risk.The Journal of Thoracic and CaRates of stroke (2.1% vs 1.2%), aortic dissection (0.2%
vs 0%), groin complications (2% vs 0%), and phrenic
nerve palsy (3% vs 0%) were significantly increased.
Although rates of postoperative bleeding requiring reop-
eration were slightly higher numerically in our minimally
invasive groups (although not significantly), transfusion re-
quirements were significantly lower in the minimally inva-
sive matched cohorts. This relationship is likely because
these variables describe different types of bleeding. Explo-
ration for postsurgical hemorrhage is typically related to an
unnoticed or late arterial bleed, usually arising from a chest
wall port site in patients undergoing minithoracotomy. On
the other hand, blood product transfusions are related to
overall blood loss. As proposed by Svensson and col-
leagues14 in their analysis of mitral valve surgery through
a lower hemisternotomy approach, less overall blood loss
is likely because of less extensive mediastinal dissection
during minimally invasive surgery. Of note, overall rates
of reoperation in our study were less than 1.5% and are
among the lowest reported to date.
The benefit of minimally invasive approaches to mitral
surgery on pulmonary function is contradictory. In the pres-
ent study, duration of ventilator support was nearly equiva-
lent between the minimally invasive and sternotomy
groups. The study by Suri and colleagues13 is similar tordiovascular Surgery c Volume 145, Number 3 753
Acquired Cardiovascular Disease Goldstone et al
A
C
Dour own and included a subset of patients from our health
system. Although they found that port access was indepen-
dently associated with a slightly decreased length of postop-
erative ventilatory support, the study population included
patients from 2 reference centers. Within our health system,
such a differencewas not observed, and we agree that differ-
ent postoperative management strategies between surgical
teams likely account for the differences in time to extuba-
tion and discharge between published series.
All patients left the operating room with mild or less MR
regardless of the surgical approach. Nevertheless, in both
matched comparisons a minithoracotomy approach seemed
to facilitate a more effective immediate repair. However,
subsequent analysis revealed that a greater proportion of
patients who underwent repair via median sternotomy had
bileaflet prolapse, and repair techniques did differ between
groups. This discrepancy may have contributed to the dif-
ferences noted in post-repair MR. Yet, because the mitral
valve lies in an annular plane that nearly approximates the
sagittal plane of the body, a right lateral approach often
provides a better en face view of the valve than median ster-
notomy. In addition, the feasibility of complex valve repair
via a right lateral approach has been well described.25,26 It is
important to note that a minimally invasive approach did not
significantly increase the rate of a failed mitral valve repair
resulting in replacement, and an overall repair rate of 99%
was achieved in patients with degenerative mitral valve
disease. Near 100% repair rates for mitral valve prolapse
have recently been reported via sternotomy approaches.27
Although a number of series have reported trends toward
shorter hospital stays in patients who undergo minimally in-
vasive mitral valve surgery,15,24,28,29 we were unable to
demonstrate such an effect. Shorter times to extubation and
discharge result in lower hospital costs and less resource
utilization, and are key arguments of robotic surgery
advocates. Our data from the overall matched analysis do
support a lower rate of early rehospitalization after surgery
with a minimally invasive approach. This may have
significant ramifications on cost analysis because
readmissions are expensive, and Medicaid and Medicare no
longer reimburse treatment of preventable events. However,
because this trend was not observed in the degenerative
cohort, the effect may be related to the pathology and not
the procedure.
Observed differences in clinical outcomes between the
minimally invasive and sternotomy groups in our study
were negligible in a homogenous group of patients with de-
generative mitral valve disease, as well as for all etiologies.
Indices of postoperative morbidity and mortality were ex-
tremely low, and efficacy of repair and long-term survival
were excellent in both matched groups. Our data add to
that of other reference centers to support the noninferiority
of minimally invasive mitral valve repair.8-10,13-15 Clearly,
as in the case of all fledgling techniques, outcomes rely754 The Journal of Thoracic and Cardiovascular Surgon operator experience. Yet, in our experience with
isolated mitral valve disease of any cause, a right
minithoracotomy or sternotomy approach may be used
without compromising clinical outcome. Mortality rates
less than 0.5%, stroke rates less than 1%, and reduction
of MR to mild or less must be standards against which
future percutaneous valve therapies are compared in
average-risk surgical candidates. It is particularly important
that outcomes are excellent in patients with degenerative
mitral valve disease, because guidelines now recommend
early surgery for asymptomatic patients with severe MR.19
Providing patients the option of a cosmetically favorable
procedure without sacrificing efficacy and long-term dura-
bility will hopefully facilitate early surgical correction of
MR before the development of left ventricular dysfunction.
Study Limitations
The limitations of the present study include its retrospec-
tive methodology. Treatment allocation bias certainly exists
when comparing patients who underwent minimally inva-
sive and conventional sternotomy approaches to mitral
valve surgery. Patients selected for minimally invasive mi-
tral surgery tend to be less sick, have fewer comorbidities
and are often earlier in the course of their disease. Although
propensity score matching helps account for such bias, it se-
lects for patients of intermediate risk, because patients on
either end of the probability spectrum are typically un-
matchable. However, the distribution of propensity scores
in our matched cohorts did closely approximate the distri-
bution of propensity scores for the entire study population.
Thus, a wide range of risk profiles was included in the pres-
ent study to minimize limitations on generalizability. To our
knowledge, this is the largest propensity score–matched
comparison of mitral valve repair via right minithoracot-
omy and conventional sternotomy to date. Nevertheless, be-
cause the study population was derived from a single
reference health system, external validity is partially limited
at the expense of enhancing internal validity. Moreover, the
data reported cannot be construed as equivalent to that of
a large randomized controlled trial, which may be ethically
infeasible.
CONCLUSIONS
Despite longer operative times, minimally invasivemitral
valve repair affords no apparent disadvantages compared
with valve repair via conventional sternotomy. In what we
believe to be the largest propensity-matched analysis of iso-
lated mitral valve repair via right minithoracotomy to date,
we demonstrate in a health system–wide study that a mini-
mally invasive approach facilitates at least equivalent mitral
valve repair, with a near 100% repair rate, fewer transfu-
sions, and lower early readmission rates. Ideally, the nonin-
feriority of minimally invasive mitral valve repair may help
improve referral rates of patients with MR before theery c March 2013
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Ddevelopment of adverse sequelae of the disease. In addition,
the excellent results of minimally invasive mitral valve sur-
gery should be used as the reference standard against which
future percutaneous platforms for mitral valve surgery are
compared.
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APPENDIX 1. Multivariable logistic regression to model a dichotomous outcome of minimally invasive or open repair: Overall analysis
Variable Coefficient ß OR* 95% CI P value
Age 0.007 1.01 (0.99-1.02) .4
BMI (vs>30 kg/m2)
Underweight (<18.5 kg/m2) 0.446 2.21 (0.54-9.01) .4
Normal (18.5-25 kg/m2) 0.189 1.18 (0.69-1.99) .4
Overweight (>25 kg/m2) 0.088 1.55 (0.92-2.61) .7
Female gender 0.081 1.18 (0.79-1.74) .4
NYHA functional class I 0.207 1.51 (1.01-2.27) .05
Degenerative cause 0.033 0.94 (0.53-1.64) .8
Chronic lung disease 0.129 1.29 (0.69-2.42) .4
Severe MR 0.525 2.86 (1.16-7.06) .02
Greater than mild tricuspid regurgitation 0.694 0.25 (0.16-0.39) <.001
Ejection fraction (%) 0.009 1.01 (0.99-1.03) .3
Previous cardiac intervention 0.021 1.04 (0.54-2.00) .9
Type II MR 0.353 2.02 (0.93-4.40) .07
Intercept 1.989
OR, Odds ratio; CI, confidence interval; BMI, body mass index; NYHA, New York Heart Association; MR, mitral regurgitation. *OR represents minimally invasive sternotomy.
c-statistic 0.71; median difference in propensity scores of matched pairs 0.0015 (interquartile range, 0.0005-0.008).
APPENDIX 2. Multivariable logistic regression to model a dichotomous outcome of minimally invasive or open repair: Degenerative cause
analysis
Variable Coefficient ß OR* 95% CI P value
Age 0.007 1.01 (0.99-1.03) .4
BMI (vs>30 kg/m2)
Underweight (<18.5 kg/m2) 0.085 1.53 (0.28-8.46) .9
Normal (18.5-25 kg/m2) 0.034 1.36 (0.72-2.55) .9
Overweight (>25 kg/m2) 0.287 1.87 (1.0-3.51) .3
Female gender 0.073 1.16 (0.74-1.82) .5
NYHA functional class I 0.277 1.74 (1.11-2.74) .02
Chronic lung disease 0.284 1.77 (0.83-2.74) .1
Severe MR 0.540 2.94 (0.75-11.51) .1
Greater than mild tricuspid regurgitation 0.661 0.27 (0.16-0.44) <.001
Ejection fraction (%) 0.001 1.00 (0.98-1.02) .9
Previous cardiac intervention 0.167 0.72 (0.28-1.84) .5
Intercept 1.270
OR, Odds ratio; CI, confidence interval; BMI, body mass index; NYHA, New York Heart Association; MR, mitral regurgitation. *OR represents minimally invasive sternotomy.
c-statistic 0.70; median difference in propensity scores of matched pairs 0.0025 (interquartile range, 0.0007-0.009).
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